Meshy
Meshy Raises Nearly $400M Series B at a $1.5B Valuation
Meshy announced ~$400M in Series B financing on July 21, 2026. AI 3D-generation company Meshy raised nearly $400 million in a Series B at a $1.5 billion valuation, the largest disclosed round in its category.
Round details
The financing includes backing from Monolith Capital, IDG Capital, Matrix Partners China. The company reported a $1.5B valuation alongside the transaction.
- Round: Series B
- Capital announced: ~$400M
- Headquarters: Silicon Valley, CA
How the company plans to use the capital
Meshy is scaling models and product infrastructure for generating editable 3D assets from text and image inputs across gaming, commerce, media, and industrial design.
Why this matters for GTM teams
The financing shows that generative AI investment is broadening beyond text, image, and video into production-grade spatial and 3D content.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Meshy company announcement.
Company Info
Investors (3)
Share
Related Reports
Armadin Raises $255.5M Series B for Autonomous Security
Armadin raised a $255.5 million Series B co-led by Andreessen Horowitz and Accel to scale its agentic security platform and its research, training, and go-to-market efforts.
Homeward Raises $120M Series D for Cash Offer and Bridge Financing
Homeward raised a $120 million Series D led by Saluda Grade, plus $330 million in asset-backed debt, to expand cash offer and bridge financing for real estate agents.
Varda Raises $251M Series D for Space-Based Pharmaceutical Processing
Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital to scale space-based pharmaceutical processing.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free